Insect Cell Lines Market Outlook:
Insect Cell Lines Market size was over USD 1.23 billion in 2025 and is projected to reach USD 3.65 billion by 2035, witnessing around 11.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of insect cell lines is evaluated at USD 1.36 billion.
The reason behind the growth is due to the increasing production of vaccines. Several veterinary and human vaccines are commercially produced using the baculovirus-insect cell expression method that are desirable for high-level eukaryotic protein synthesis. There are already around 1 billion doses of vaccine produced each month by producers globally, and this number will increase to over 10 billion by the end of 2021, and, overall vaccine production reach over 22 billion by June 2022.
The rising need for insect-derived products is believed to fuel the insect cell lines market. Insects have recently been suggested as one of the most viable alternatives to animal protein which has led to the production of health-related products by insect cell lines using vectors created from insect viruses in insect cells, which give high levels of protein expression.
